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The ability of the human immune system to protect against infectious disease declines
with age and efficacy of vaccination reduces significantly in the elderly. Aging of
the immune system, also termed as immunosenescence, involves many changes in
human T cell immunity that is characterized by a loss in naïve T cell population and
an increase in highly differentiated CD28- memory T cell subset. There is extensive
data showing that latent persistent human cytomegalovirus (HCMV) infection is also
associated with age-related immune dysfunction in the T cells, which might enhance
immunosenescence. Understanding the molecular mechanisms underlying age-related
and HCMV-related immunosenescence is critical for the development of effective
age-targeted vaccines and immunotherapies. In this review, we will address the role of
both aging and HCMV infection that contribute to the T cell senescence and discuss the
potential molecular mechanisms in aged T cells.
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THE AGING IMMUNE SYSTEM
The human immune system must fight diverse pathogens and provide sufficient host protection
throughout life. Memory T cells, which differentiate from naïve T cells upon primary antigenic
stimulation and enable a rapid and robust response to previously encountered pathogens,
are key players in adaptive immunity. The generation and maintenance of pathogen-specific
memory T cells is crucial for life-long immune protection and effective vaccination (Farber et al.,
2014). However, profound changes occur in the human immune system over time, known as
immunosenescence. These age-related changes contribute to decreased immune protection against
infections and diminished responses to vaccination in the elderly. Changes in T cell immunity
appear to be have the most impact (Miller, 1996; Cambier, 2005).
Although T cell numbers remain more or less constant over the human lifespan, pronounced
age-associated changes occur in T cell composition (naïve vs. memory T cell subsets). It is
well accepted that the functional naïve T cell output decreases after puberty due to thymic
involution, resulting in increased homeostatic proliferation of existing naïve T cells and eventually
phenotypic conversion of naïve T cells into virtual memory cells (Nikolich-Žugich, 2008, 2014;
Goronzy et al., 2015; Jacomet et al., 2015). In contrast to the shrinking naïve compartment and its
impaired ability to activate and differentiate with age, the proportion of memory T cells increases
during early life, remains stable throughout adulthood, but starts to show senescent changes after
about 65 years (Farber et al., 2014). In humans, circulating memory T cells can be subdivided
into two major phenotypically and functionally distinct populations: central memory T cells
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(TCM; CD45RA−CCR7+CD62L+), which are largely confined
to secondary lymphoid tissues, and effector memory T cells
(TEM; CD45RA−CCR7−CD62L−), which can traffic to multiple
peripheral compartments (Sallusto et al., 1999; Mueller et al.,
2013; Farber et al., 2014). TCM cells are enriched for CD4+ T cells,
while TEM cells are predominantly CD8+ T cells in human blood
(Moro-García et al., 2013).
One of the most prominent T cell changes to occur with
age is the loss of the co-stimulatory molecule CD28 and
the progressive accumulation of highly differentiated CD28−
TEM cells (CD45RA+CD28−CCR7−CD62L−), mainly in the
CD8+ T cell population (Koch et al., 2008). These cells are
characterized by decreased proliferative capacity, shortened
telomeres, a reduced TCR repertoire, and enhanced cytotoxic
activity. As CD28 is crucial for complete T cell activation, CD28
loss is associated with increased susceptibility to infections and
a weakened immune response to vaccination in older people
(Saurwein-Teissl et al., 2002; Almanzar et al., 2005; Sansoni
et al., 2008; Moro-García et al., 2013). However, CD28− T
cells are not anergic, so they might also play a role in tissue-
mediated immunity (CD8+CD28− T cells) (Flavell et al., 2013)
and cytomegalovirus (CMV) infection control (CD4+CD28− T
cells) (Moro-García et al., 2013). Further studies to explore the
generation and maintenance of CD28− T cells, especially in
different disease states, will help establish their immune function
and enhance our understanding of human T cell aging.
It is thought that the memory T cells generated in youth
are well preserved and remain strongly protective over decades
(Hammarlund et al., 2003, 2005), while T cell memory responses
first derived in old age are severely impaired (Haynes et al.,
2003; Weinberger et al., 2008; Nikolich-Žugich and Rudd, 2010;
Valkenburg et al., 2012). Therefore, age-targeted vaccines and
immunotherapies are required.
The ability to generate protective immune responses largely
depends on the generation and maintenance of a diverse and
well-balanced T cell repertoire. Several studies have shown
contraction in T cell diversity corresponding to a shrinkage in
the naïve T cell compartment in elderly individuals due to thymic
involution (Naylor et al., 2005; Britanova et al., 2014). However,
these studies do not take the dramatic influence of latent
persistent infection into account, particularly CMV infection,
which is known to be associated with age-related alterations
in the T cell pool and function. Recent evidence suggests that
homeostatic proliferation maintains the naïve CD4+ T cell
compartment and its diverse repertoire, but not naïve CD8+ T
cells, in CMV-negative individuals. A decline in naïve CD4+
T cell subsets occurs in the presence of CMV, but there is no
depletion of naïve CD8+ T cells (Wertheimer et al., 2014). In
principle, thymic involution should have an equal impact on both
CD4+ and CD8+ T cells. Therefore, the differences seen between
the two subsets suggest that shrinkage of the naïve CD8+ T cell
pool is more likely to be due to increased development of virtual
memory T cells (which are well characterized in murine models
Sprent and Surh, 2011; Renkema et al., 2014) than the defective
regeneration ability of an aged thymus. Moreover, unprimed
“innate/memory-like” CD8+ T cells have recently been identified
in humans (Jacomet et al., 2015). Taken together, these data imply
that thymic involution might be less important for maintaining
T cell diversity than previously thought. Characterization of the
epigenetic signatures and transcriptional profiles of these virtual
memory T cells will help explain how antigen-inexperienced T
cells acquire the memory phenotype and how they contribute to
the aging immune system.
Given that polyfunctional T cells confer a more effective
immune response to infections (Yamamoto et al., 2009; Boyd
et al., 2015; Snyder et al., 2016), it is important to investigate
the impact of aging on T cell polyfunctionality. Van Epps et al.
demonstrated enhanced polyfunctionality in CD8+ TEM cell
subsets in older individuals, but both CD4+ and CD8+ TCM
cells exhibited an age-associated decline in polyfunctionality
(Van Epps et al., 2014). However, the CMV-seropositive reaction
was again not examined, and the possibility that increased
polyfunctional CD8+ TEM cells may be due to repeated antigenic
stimulation could not, therefore, be excluded.
Despite intensive studies of T cells providing some insights
into immune system aging, they have a number of limitations
that need to be taken into consideration in future investigations.
First, most of our current knowledge on T cell aging is based
on studies of circulating peripheral blood T cells, which only
represent 2% of the total T cell pool (Farber et al., 2014).
Circulating memory T cells predominantly reside in tissues
other than the blood (Mueller et al., 2013). In addition, a
non-circulating subset of memory T cells has recently been
identified and designated tissue-resident memory T cells (TRM;
CD45RA−CCR7−CD62L−CD69+), which permanently reside
in peripheral tissues and enhance local immunity during
infections (Mueller et al., 2013; Farber et al., 2014; Clark, 2015).
However, age-related changes in naïve and memory T cells in
distinct human organs have only rarely been studied (Lazuardi
et al., 2005; Herndler-Brandstetter et al., 2012; Sathaliyawala et al.,
2013). Second, most studies are limited to the total CD4+ T
cell pool with only a few studies conducted in Th1 and Th2
CD4+ T cell subsets, and even less is known about the impact
of aging on other lineages, such as Th17 cells (Huang et al., 2008;
Tesar et al., 2009; Lee et al., 2011; Lim et al., 2014), regulatory
T cells (Tregs) (Fessler et al., 2013; Garg et al., 2014), and
Tfh cells (Winkler and Waisman, 2014; Zhou et al., 2014).
Finally, human memory T cells are generated and maintained
in the context of exposure to diverse viral infections throughout
life, particularly CMV infection (over 90% of young people
in developing countries) (Arens et al., 2015). It is well-known
that CMV plays an important role in human memory T cell
function with aging. Therefore, distinguishing CMV seropositive
individuals from others is important to provide a more accurate
understanding of age-related memory T cell immunity. The
enormous impact of CMV infection on T cell function with aging
is further discussed below.
MOLECULAR MECHANISMS OF T CELL
SENESCENCE
Although the impact of aging on T cells is relatively well
described at the cellular level, the molecular mechanisms of
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aging are rather less well understood. There is growing evidence
that altered transcription (Chen et al., 2013) and epigenetic
regulation (Ponnappan and Ponnappan, 2011) are involved in T
cell senescence.
A major feature of immunological memory is the ability
of T cells to remember their previous transcriptional profile
and propagate their gene expression pattern to progeny, termed
“adaptive transcriptional memory” (Turner, 2003; Kundu and
Peterson, 2009). In transcriptional or epigenetic memory, genes
are marked with active epigenetic signatures that are maintained
throughout multiple cell divisions. These marks facilitate more
efficient and robust transcription upon encountering a secondary
stimulus (Zediak et al., 2011).
Chen et al. provided an excellent overview of the impact
of aging on genome-wide transcriptional profiles in CD4+ and
CD8+ T cells (Chen et al., 2013). For example, CD8+ T
cells (Fann et al., 2005), and to a lesser degree CD4+ T
cells (Czesnikiewicz-Guzik et al., 2008), decrease CD28 gene
expression with age, with CD28+ and CD28− CD8+ memory
T cells showing different transcriptional profiles. There was
elevated expression of several transcription factors including
T-bet, eomesodermin (EMOES), and MYC (Fann et al., 2005)
in CD28− memory T cells. T-bet and EMOES play crucial
roles in the acquisition of T cell effector functions and memory
development in CD8+ T cells and regulate IFN-γ, granzyme
B, and perforin expression (Angelosanto and Wherry, 2010),
suggesting that they might critically mediate the enhanced
cytotoxicity of CD28−CD8+ memory T cells. In addition,
mammalian target of rapamycin (mTOR) has been shown to
modulate memory CD8+ T cell formation by regulating T-
bet and EMOES gene expression. mTOR inhibition promotes
T cell memory by repressing T-bet and inducing EOMES
(Rao et al., 2010). Remarkably, the mTOR inhibitor RAD001
has recently been reported to improve immune responses to
influenza vaccination in elderly volunteers, but the underlying
mechanism remains obscure (Mannick et al., 2014). Two
possible mechanisms might explain this observation. First, T-
bet expression is higher in terminally differentiated TEM cells
(Joshi et al., 2011), while EOMES is highly expressed in
persistent TCM cells (Banerjee et al., 2010). Therefore, RAD001
might restrain the conversion of memory T cells to a highly
differentiated phenotype, such as CD28− TEM cells, by reducing
T-bet expression in the elderly. As a consequence, T cell
senescence is suppressed and the immunological function of
memory T cells enhanced. Second, T-bet is also the master
regulator of Th1 cell differentiation but is inhibitory in Th2
and Tfh cell lineage development (Lazarevic et al., 2013). Zang
et al. found a Th1 CD4+ subset shift and reduced Th2/Tfh
cell differentiation in aged mice (Zhang et al., 2014). Hence,
the decrease in T-bet caused by RAD001 might enhance Th2
and/or Tfh CD4+ cell development, which is crucial for B
cell immunity and antibody production. This latter hypothesis
is further supported by clinical observations of an increased
antibody response in elderly volunteers receiving the influenza
vaccination (Mannick et al., 2014). Further studies of cellular
and molecular changes occurring in these different subsets are
needed.
Numerous studies have shown that epigenetic mechanisms
including DNA methylation, histone modifications, chromatin
structure alterations, and microRNA regulation play an essential
role in transcriptional memory by regulating gene expression
in memory T cells (Gibney and Nolan, 2010). It is well-known
that genome-wide decreases in the methylation of repetitive
elements (particularly Alu sequences) and gene coding regions
occur during aging (Bollati et al., 2009; Heyn et al., 2012; Salpea
et al., 2012). These age-dependent DNA methylation changes
also occur in immune-specific genes that contribute to T cell
senescence (Shanley et al., 2009; Fernández-Morera et al., 2010;
Hongdong et al., 2015; Tserel et al., 2015).
Although the age-associated DNA methylation signatures
that mark immune responsive genes are well documented,
little is known about the contribution of site-specific histone
modifications to immunosenescence. Histone acetylation,
methylation, phosphorylation, and ubiquitination all regulate
transcription by altering chromatin accessibility (Strahl and
Allis, 2000; Kouzarides, 2007). Early epigenetic studies in
rat livers showed significant decreases in histone acetylation
(H3K9ac) and H3 phosphorylation (H3S10ph) contributing
to age-associated decreases in transcription (Kawakami et al.,
2008). More recently, Sidler et al. demonstrated profound
age-dependent changes in gene expression accompanied by
decreases in DNA methylation, H3K9me3, and H4K16ac in
the rat spleen and thymus, suggesting increased chromatin
instability with age. Moreover, several transcription factors
(BCL6, MYC, TCF7, and ETS1) with decreased expression in
the thymus and increased expression in the spleen are thought
to be associated with immunosenescence (Sidler et al., 2013).
Since these transcription factors play crucial roles in homeostatic
proliferation, differentiation, and activation in T lymphocytes
(Muthusamy et al., 1995; Angelosanto and Wherry, 2010), their
opposing transcriptional profiles in the thymus and spleen
might contribute to the distinct senescence phenotype observed
during aging, i.e., the reduced thymic naïve T cell output
and increased homeostatic proliferation of peripheral T cells.
Chromatin immunoprecipitation (ChIP) studies to identify
genome-wide epigenetic signatures with characterization of
chromatin accessibility in these regions might provide insights
into the epigenetic regulation of immunosenescence.
Several recent studies have explored microRNA regulation
in T cell aging. For example, miR-92a expression significantly
declined in CD8+ T cells during aging, which also correlated
with reduced naïve CD8+ T cell numbers. It has also been
suggested that the progressive decline in miR-92a expression
may be associated with a reduced naïve T cell repertoire due to
repeated stimulus exposure (Ohyashiki et al., 2011). Moreover,
an age-dependent decline in miR-181a, an intrinsic regulator of
TCR signaling (Li et al., 2007), was observed in aged CD4+ T
cells (Li et al., 2012). miR-181a loss increased DUSP6 activity,
which eventually impaired TCR sensitivity in elderly CD4+ T
cells (Li et al., 2012). Compared to CD8+CD28+ T cells, highly
differentiated CD8+CD28− T cells overexpressed miR-24, which
was associated with downregulation of the histone variant H2AX
and consequent impairment of the response to DNA damage
and increased susceptibility to apoptosis in CD8+CD28− T cells
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(Brunner et al., 2012). Taken together, these studies suggest
that microRNAs are causative in immunosenescence and might
be useful biomarkers of T cell aging. However, a systematic
survey of microRNAs, their direct targets, and function in
immunosenescence are needed. Comprehensive studies in well-
defined human T cell subsets in both health and disease
will enhance our understanding of the molecular mechanisms
responsible for age-related T cell impairment so that effective
interventional strategies against age-associated diseases can be
developed.
Apart from genetic/epigenetic inheritance, lifestyle and
environmental factors, such as nutritional status and metabolism
also have a significant impact on the human immune system
and lifespan (Fuente, 2014). There is good evidence that diets
that contain particular nutrient or non-nutrient components can
significantly enhance immune function in the elderly (Lesourd
et al., 1998; Pae et al., 2011; Maijó et al., 2014). For example,
dietary manipulation of the availability of methyl donors
can extend and maintain immune function by epigenetically
modulating methylation in mice (Miller et al., 2005). The
mTOR pathway has provided a focus for understanding how
metabolism regulates T cell immunity: upon growth factor
stimulation, the PI3K/Akt/mTOR pathway is activated that,
in turn, promotes nutrient uptake, enhances many metabolic
activities, and results protein biosynthesis in T cells (Jones and
Thompson, 2007). The mTOR inhibitor rapamycin promotes
CD8+ T cell memory development (Araki et al., 2009), which
might be due to metabolic changes in CD8+ T cells (Peng
et al., 2002; Sipula et al., 2006; Brown et al., 2007). Moreover,
mTOR plays a crucial role in the regulation of effector and
regulatory T cell lineage commitment (Delgoffe et al., 2009),
since it not only acts as a regulator of translation but also
functions as an intracellular energy sensor that positively and
directly regulates mitochondrial respiration (Desai et al., 2002;
Ramanathan and Schreiber, 2009). A study of energy metabolism
has shown that highly differentiated CD8+CD28− T cells utilize
different metabolic strategies than normal CD8+ memory T cells
(Henson et al., 2014); in contrast to the quiescent catabolic
metabolism in CD8+CD28+ memory T cells, CD8+CD28− T
cells have lower mitochondrial mass and respiration, high basal
glycolysis levels, and impaired metabolism due to increased ROS
levels (Henson et al., 2014). Further, CD8+CD28− T cells favor
the use of the cytosolic glycolytic pathway over mitochondrial
respiration for energy production. Aerobic glycolysis is a critical
metabolic pathway required for the production of the effector
cytokine IFN-γ, consistent with the enhanced cytotoxic activity
of CD8+CD28− T cells (Chang et al., 2013; Gubser et al., 2013).
As mitochondrial function is compromised during aging (Ron-
harel et al., 2015), a switch to energy generation by glycolysis may
produce a population of CD8+CD28− T cells with the metabolic
advantage to outcompete other T cell subsets competing for
nutrients and factors required for survival and function. These
data highlight the important role played by nutrient status and
metabolic regulation in enhancing T cell immunity and might
be a promising approach to promote healthy aging through
nutritional and metabolic interventions.
HUMAN CMV INFECTION, MEMORY
INFLATION, AND IMMUNOSENESCENCE
Cytomegalovirus (CMV) is an ubiquitous β-herpesvirus with a
double-stranded DNA genome that has co-evolved with humans
over millions of years (Sinclair and Sissons, 2006; Gibson, 2008).
Human CMV (HCMV) is a prevalent human pathogen, infecting
40–100% of world’s population. CMV has the capacity to induce
both lytic and latent infections to establish lifelong persistence in
human hosts following primary infection (Cannon, 2009; Ludwig
and Hengel, 2009; Cannon et al., 2010). In lytic infection, HCMV
undergoes temporally active replication that can be divided into
immediate early (IE), early (E), and late (L) phases. The most
crucial viral lytic gene products are viral IE genes, which control
subsequent viral gene expression and virus replication. Thus,
these major IE gene products essentially determine the HCMV
infection states: latency (IE genes suppressed) or reactivation (IE
genes expressed) (Sinclair and Sissons, 2006; Paulus and Nevels,
2009). The latent phase of HCMV infection is characterized
by viral quiescence, in which the viral genome is maintained
as an extra-chromosomal plasmid in the absence of detectable
production of infectious virions but able to reactivate to specific
stimuli (Goodrum et al., 2002; Reeves et al., 2005; Sinclair and
Sissons, 2006). Despite infecting a broad range of host cells,
HCMV usually establishes viral latency at specific cellular sites,
predominantly CD34+ progenitors and myeloid lineage cells
(Hahn et al., 1998; Goodrum et al., 2002).
Primary HCMV infection elicits extensive innate and adaptive
immune responses. Thus, to escape host antiviral responses,
HCMV has developed diverse immune evasion strategies to alter
host immune recognition during both lytic and latent infection.
In particular, HCMV restricts major histocompatibility complex
(MHC) class I and II antigen presentation, which allows the
virus to survive, disseminate, and persist in infected individuals
(Noriega et al., 2012). In immunocompetent individuals, both
primary and lifelong persistent HCMV infections generally
remain subclinical and well controlled by the host immune
system. T cell responses are particularly important for controlling
viral latency in infected individuals (Hanley and Bollard, 2014;
Klenerman and Oxenius, 2016). During the early phases of
primary infection, the initial T cell response to HCMV is
dominated by circulating HCMV-specific CD4+ T cells that
produce the Th1 cytokines IFN-γ and TNF-α (Rentenaar et al.,
2000; Gamadia et al., 2003). Highly cytotoxic HCMV-specific
CD8+ T cells can be detected in the blood several days after the
initial CD4+ T cell response, and they are maintained with an
effector phenotype during the latent phase to prevent HCMV
reactivation and to protect the host from re-infection (Polic´ et al.,
1998; Kuijpers et al., 2003; Mackus et al., 2003). In addition, the
humoral response to HCMV also contributes to controlling the
viral load and preventing primary infection in humans (Gerna
et al., 2008; Genini et al., 2011; Jackson et al., 2011; Alonso Arias
et al., 2013). After primary infection, B cells are activated by
antigens with the help of HCMV-specific CD4+ T cells, mainly
Th2 cells, leading to the production of antibodies specific for a
number of HCMV proteins (Wang and Shenk, 2005; Gerna et al.,
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2008; Macagno et al., 2010; Genini et al., 2011). These HCMV-
specific antibodies can block viral dissemination and control the
infection by neutralizing extracellular virions, a mechanism that
is particularly important for protecting the fetus from congenital
HCMV infection (Fowler et al., 1992; Revello and Gerna, 2002;
Schleiss, 2013).
However, long-term HCMV persistence has a profound
impact on the immune system’s composition and function, even
in healthy HCMV-infected individuals, especially with respect
to CD8+ T cells. One hallmark of latent HCMV infection is
the progressive and substantial expansion of HCMV-specific
memory CD8+ T cells over time, with HCMV-specific memory
CD4+ T cells accumulating to a lesser extent (Klenerman and
Oxenius, 2016; Weltevrede et al., 2016). This accumulation
of HCMV-specific memory T cells during viral persistence is
termed “memory inflation,” first defined in the mouse CMV
(MCMV) infection model (Karrer et al., 2003). HCMV-specific
memory T cells tend to gradually increase in number with
age: in HCMV-infected elderly individuals, the CD8+ T cell
response to HCMV antigens occupies nearly 50% of the entire
memory CD8+ T cell compartment in peripheral blood, while
approximately 30% of total circulating CD4+ T cells can be
HCMV responsive (Sylwester et al., 2005; Pourgheysari et al.,
2007; Li et al., 2014).
Human cytomegalovirus (HCMV) persistence is thought to be
a driver of immunosenescence in humans (Koch et al., 2007).
The majority of HCMV-specific inflationary T cells are TEM
cells with the typical age-related senescent T cell phenotype.
These terminally differentiated HCMV-specific T cells generally
acquire CD57 and CD45RA expression but lack CD28 and CCR7
expression (CD45RA+CD57+CD28−CCR7−) (Gamadia et al.,
2001; Appay et al., 2002; Kuijpers et al., 2003). It is widely
accepted that late-stage differentiated CD28− T cells are a major
characteristic of T cell aging, suggesting that persistent HCMV
infection is associated with immunosenescence. This is further
supported by the fact that the large population of HCMV-
specific CD8+CD28− TEM cells that usually accumulate during
HCMV persistence are absent in HCMV-seronegative elderly
individuals, even those infected with other persistent herpes
viruses (Chidrawar et al., 2009; Derhovanessian et al., 2010).
Several studies have shown that acute viral infections generate
polyfunctional memory CD8+ T cells with re-expressed CD45RA
(Precopio et al., 2007; Miller et al., 2008; Akondy et al., 2009).
Live yellow fever vaccine (YF-17D)-specific memory CD8+
T cells exhibited a terminally differentiated CD45RA+CCR7−
phenotype but remained polyfunctional with robust proliferative
potential 5–10 years post vaccination, which may suggest that re-
expressed CD45RA biomarks highly functional memory T cells
after acute viral infections rather than senescent T cells (Akondy
et al., 2009). However, these YF-17D-specific memory cells were
not “true” late-stage differentiated CD28− T cell subsets but
CD27+CD28+ cells. Therefore, the use of CD45RA alone as a
marker of T cell differentiation and function is questionable.
In fact, the CD45RA+CCR7−CD8+ subtype represented resting
memory T cells that could be re-activated upon antigenic
stimulation. It has also been shown that CD45RA re-expression
on memory T cells can occur in the absence of further antigenic
stimulation, which is indicative of the time elapsed since previous
viral infection rather than the functional potential of CD8+
T cells (Carrasco et al., 2006). In addition, CD45RA+CD8+
memory T cells did not accumulate with age and showed
no correlation with the CD28−CD8+ TEM subset (Mahnke
et al., 2013). Thus, CD28 is a more reliable surface marker
for the phenotypic and functional definition of human T cell
differentiation. In contrast to age-dependent T cell senescence,
increased HCMV-specific memory CD8+ profiles (up to 10%
of the total CD8+ T cell memory pool) were observed even
in young hosts, suggesting that progressive clonal expansion
may lead to immunosenescence at an earlier age in HCMV-
infected individuals (Khan et al., 2004; Chidrawar et al., 2009).
However, the high frequency of HCMV-responsive T cells may be
a “necessary evil” to restrain HCMV re-activation and maintain
control of latent HCMV throughout life (Pawelec, 2005).
There is increasing evidence to suggest that memory inflation
in HCMV infection is associated with impaired T cell immunity
in elderly hosts. Despite the CD8+ T cell repertoire being
diverse enough to recognize different viral epitopes soon after
primary HCMV infection, clonal diversity starts to shrink with
age, with a large proportion of the repertoire limited to a
few high-avidity clones with a replicative senescent phenotype
(Day et al., 2007). In particular, T cell responses specific to an
individual immunodominant HCMV epitope [such as 65kDa
phosphoprotein (p65) and 55kDa IE protein 1 (IE1)] can
comprise over 25% of the total CD8+ T cell population in
elderly individuals (Khan et al., 2002; Sylwester et al., 2005).
Thus, the excess expansion of a single HCMV-specific repertoire
in memory inflation may compromise immune protection in
response to novel and vaccine antigens by decreasing TCR
diversity in the elderly. This renders individuals with only limited
virus-specific T cell clones at risk of life-threatening diseases
as they get older (Klenerman and Oxenius, 2016). Additionally,
memory inflation in latent HCMV infection may also impact
the balance between Th1 and Th2 cytokine production by
CD4+ T cells in aged individuals, shifting it in favor of Th1
responses (Saurwein-Teissl et al., 2002; Pawelec et al., 2005).Most
inflationary memory CD4+ T cells are IFN γ-producing Th1
cells, which might explain the poor antibody-mediated immune
responses seen in the elderly (Rentenaar et al., 2000; Bitmansour
et al., 2002; van Leeuwen et al., 2006). Indeed, HCMV-specific
CD4+ T cells were negatively associated with humoral responses
to influenza vaccination (Derhovanessian et al., 2013). However,
the precise mechanism underlying memory inflation is not
fully understood, the current hypothesis being that continuous
repetitive antigen exposure during latent HCMV infection
contributes to immune system reshaping and enhances the age-
related changes in T cell compartments in older adults (Pawelec
et al., 2009; O’Hara et al., 2012).
Decreased levels of naïve T cells are also a hallmark
of immunosenescence. Several cross-sectional studies have
indicated that HCMV has much less of an impact on the naïve
T cell pool than on memory T cells (Mekker et al., 2012;
Wertheimer et al., 2014), but HCMV status is significantly
associated with changes in naïve CD4+ T cells (Wertheimer
et al., 2014). Lower levels of naïve CD4+ T cells appear to
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FIGURE 1 | Model of age- and HCMV-related immunosenescence. Thymic involution contributes to reduced naïve T cell export and T cell diversity with age. To
compensate for inadequate thymic export, existing naïve T cells increase homeostatic turnover. Upon antigen stimulation, a large number of terminally differentiated
CD45RA+CD8+ TEM cells clonally expand in the elderly, which dominate the memory pool and further restrict repertoire diversity. These senescent CD45RA+
memory T cells typically have diminished T cell responses to stimulation in the absence of CD28 co-stimulatory signaling pathways and are characterized by a variety
of altered transcriptional profiles which are epigenetically regulated (including by DNA methylation, histone modifications, microRNAs, and chromatin remodeling). In
addition, HCMV infection can result in CD4+ naïve pool depletion and memory inflation, which further accelerate immunosenescence in aged individuals. Together,
age and HCMV infection contribute to the overall decline in immune function decline and impair the T cell response to vaccines in the elderly.
be HCMV-seropositivity dependent rather than age related,
suggesting differential effects of aging and HCMV infection on
T cell subsets (Wertheimer et al., 2014).
The “immune risk profile” (IRP) was developed as part of a
longitudinal study to predict mortality and morbidity in the aged
(Wikby et al., 2005, 2008). HCMV seropositivity was identified as
one of the immune parameters of the IRP, which also included an
inverted CD4/CD8 ratio, accumulation of CD8+CD28− T cells,
and a lower proportion of naïve cells. However, HCMV infection
was detected in very old people, compatible with the extended
lifespan observed in studies of individuals at extreme old age in
Japan. Plasma HCMV titers were not inversely correlated with
the proportion of CD28+ T cells in (semi-)supercentenarians
(105 years or older), suggesting that HCMV titers might not
be a powerful predictor of T cell senescence in successful aging
(Arai et al., 2015). Therefore, it remains controversial whether
prediction of mortality can be used as a direct indicator of
immunosenescence.
Even though pronounced memory inflation is thought to
result in the accumulation of dysfunctional CMV-specific T
cells, several studies have shown that HCMV-specific CD8+
T cells are polyfunctional in young and middle-aged hosts
and can produce multiple cytokines and induce strong effector
immune responses to staphylococcal enterotoxin B (SEB)
(Solana et al., 2012a; Pera et al., 2014; Sansoni et al., 2014;
Hassouneh et al., 2016). With increasing age, T cell exhaustion,
another form of T cell dysfunction, can arise during chronic
viral infections, such as with HIV, in which T cells are
constantly stimulated by highly replicating viruses (Wherry,
2011). Typically, exhausted T cells fail to control viral infection
as they have effector defects (Wherry, 2011) including loss of
proliferative potential, decreased cytotoxicity, impaired ability
to secrete cytokines (Frebel et al., 2010; Wherry and Kurachi,
2015), and sustained high expression of several inhibitory
receptors (e.g., PD1, KLRG1, and CD57) (Blackburn et al.,
2009). Although HCMV-specific CD8+ T cells also have low
proliferative capacity and express senescence markers, such as
KLRG1 and CD57 (Vieira Braga et al., 2015), they are not
exhausted as they are still highly cytotoxic and produce Th1
cytokines in response to sporadic viral re-activation (Klenerman
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and Oxenius, 2016). In addition, molecular profiling of HCMV-
specific CD8+ T cells has demonstrated that PD-1, an inhibitory
receptor associated with T cell dysfunction, is expressed at very
low levels in healthy individuals (Vieira Braga et al., 2015).
Therefore, persistent HCMV infection does not induce massive
exhaustion of the T cell repertoire in most immunocompetent
individuals. Indeed, HCMV is rarely reported in elderly
individuals, suggesting HCMV-specific T cells may be able
to control pathological HCMV re-activation during healthy
aging. However, the possibility remains that HCMV infection
can eventually drive the functional exhaustion of T cells and
their extensive accumulation may accelerate immunosenescence
in immunocompromised and immunosuppressed individuals
(Papagno et al., 2004; Chou and Effros, 2013; Effros, 2016).
Taken together, HCMV infection in the elderly is implicated
in immunosenescence and might have a deleterious impact on
host immunity and enhance the aging process. Nevertheless,
there remains considerable uncertainty regarding the causative
role of CMV in immunosenescence. Although it is well-
known that HCMV is a common cause of severe morbidity
and mortality in immunocompromised individuals (Reeves and
Sinclair, 2008), we cannot exclude the possibility that HCMV
might improve the polyfunctionality of CD8+ T cells and
consequently benefit the host immune system, at least in young
healthy individuals. Moreover, it is still unclear whether HCMV
re-activation occurs more frequently in the elderly than in
younger individuals. Hence, whether expansion of HCMV-
specific CD8+ T cells over time is really deleterious in old age
remains unknown. It also remains to be seen to what extent
accumulated dysfunctional inflationary memory T cells cause
immunosenescence and how deleterious these cells are on other
immune components, such as B cells, γδ T cells, and NK cells.
Finally, the host immune systemmight inefficiently control latent
HCMV reinfection during aging, thereby allowing the large-scale
expansion of virus-specific T-cell clones and further enhancing
the immunosenescent profile (Klenerman and Oxenius, 2016;
Weltevrede et al., 2016). Thus, both HCMV status and HCMV
control must be taken into account in future studies on immune
aging.
VACCINATION IN THE ELDERLY
Vaccination is the most cost-effective and efficient strategy for
improving immune responses and protecting humans from
infections and other emerging diseases. However, both the
efficacy and effectiveness of vaccination decrease in the elderly
(Jefferson et al., 2005; Chen et al., 2009; Boraschi and Italiani,
2014; Haussig et al., 2014). Given the rapidly aging population in
both developed and developing countries, improving vaccination
efficacy to promote healthy aging is a priority, not only for
individual well-being, but also for public health.
In the aged population, infectious diseases are a major
cause of morbidity and mortality, mainly because the host
immune system cannot generate adequate adaptive immune
responses to infections (Chen et al., 2009). As discussed above,
aging and latent CMV infection are closely associated with
immunosenescence by reshaping the host immune repertoire.
This can lead to increased susceptibility to severe infections due
to the progressive impairment of innate and adaptive immunity
in the elderly. In particular, significantly decreased levels of
naïve T cells with a restricted TCR repertoire and expansion of
highly differentiated memory T cells that gradually polarize to a
specific virus can compromise host immune responses to novel
virus vaccine antigens, leading to suboptimal vaccination. In
addition, impaired immune responses accompanied by repetitive
antigen exposure can result in chronic inflammation in the
elderly and are thought to contribute to the defective immune
response to vaccination by further enhancing immunosenescence
(Franceschi et al., 2000; Freund et al., 2010; Solana et al., 2012b).
Therefore, a more advanced understanding of both the cellular
and molecular basis of immunosenescence is required to develop
efficient vaccinations that better protect elderly individuals from
infections and age-related diseases.
CONCLUSIONS AND PERSPECTIVE
The adaptive immune system protects the host from numerous
pathogens over the course of human life. However, aging is
associated with a quantitative decline in immunity, particularly
in T cells, referred to as immunosenescence. Age-related T
cell senescence has been attributed to thymic involution,
contraction in the T cell repertoire, and accumulation of highly
differentiated CD28− T cells. There is growing evidence that
latent HCMV infection might accelerate immunosenescence
since it causes similar detrimental effects on T cell phenotype and
function to those found in age-associated immunological defects.
Thus, age-related and HCMV-related immunosenescence -
either together or separately - might contribute to increased
susceptibility to infectious disease and impaired immune
responses to vaccination in the elderly (Figure 1). To prevent
severe infections and promote healthy aging, efforts have been
made to improve the efficacy of vaccination in the elderly
including increased vaccine doses, prime-boost immunization
strategies, and the use of adjuvants (Couch et al., 2007; Brown,
2010; Khurana et al., 2011; Dorrington and Bowdish, 2013).
Unfortunately, these approaches have yet to significantly improve
vaccination outcomes in the older population.
There is also a considerable body of evidence to suggest
that epigenetic changes play a crucial role in natural and
pathological immune aging (Grolleau-Julius et al., 2009) and
a variety of human diseases (Barros and Offenbacher, 2009;
Hewagama and Richardson, 2009; Invernizzi, 2009; Wells,
2009). Our unpublished preliminary data suggest that the
chromatin accessibility status of certain regulatory elements, in
particular that of IL-2, alter over the human lifespan in naïve
and memory T cells. This is further supported by findings
that epigenetic regulation plays a prominent role in immune
responses and age-related differential gene expression of IL-2
(Bruniquel and Schwartz, 2003) and IFN-γ (Yano et al., 2003).
A sound knowledge of age-dependent epigenetic gene regulation
is essential for optimizing vaccination, perhaps by therapeutically
restoring immune function in the elderly. Furthermore, given the
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crucial role of HCMV in host immune function during aging, an
increased understanding of the impact of latent HCMV infection
on epigenetic signatures across regulatory elements might
provide a novel avenue for overcoming immune defects and
improving vaccine efficiency in the elderly. Integrating cellular
and epigenetic insights of immunology and virology during aging
is essential for the development of age-targeted vaccines and
age-dependent immunotherapies that exploit sustained memory
responses to pathogens.
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